`

Lyvgen Biopharma

Biotechnology

Specialities :
Antibody
Io
Immunotherapy
Drug discovery
Clinical trial

+4

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$10.0M
size-icon Size
11 - 50

Frequently Asked Questions About Lyvgen Biopharma

What does Lyvgen biopharma do?+

Lyvgen is a biopharmaceutical company focused on developing novel therapies for cancer. Lyvgens xLinkAbTM functional platform creates agonist antibodies (Abs) with tumor-localized immunostimulatory activities by balancing multiple functions of candidate Abs. Lyvgens most advanced programs include LVGN6051, a monoclonal antibody (mAb) agonist for CD137/4-1BB, LVGN7409, a mAb agonist for CD40, LVGN1673, a bispecific antibody (BsAb) blocking PD-L1 and trapping TGF1/2/3, and anti-PD-1 blocking antibody LVGN3616. Lyvgen has initiated Phase I clinical trial of LVGN6051 alone or in combination with anti-PD-1 antibody in the USA. Lyvgen plans to start Phase I testing of LVGN6051 in China, LVGN7409 and LVGN1673 globally. Lyvgen...

What are Lyvgen biopharma's specialties? +

Antibody,io,immunotherapy,drug discovery,clinical trial,cmc,cancer,immunology,and ind

What is Lyvgen biopharma's industry? +

Lyvgen biopharma operates in the Biotechnology industry.

What is Lyvgen biopharma's revenue? +

Lyvgen biopharma's revenue is 11m - 100m

What is Lyvgen biopharma's company size? +

Lyvgen biopharma has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.